Valuation: QuidelOrtho Corporation

Market Cap 1.22B 1.07B 986M 911M 1.71B 117B 1.75B 11.75B 4.61B 57.38B 4.58B 4.48B 198B P/E 2026 *
-11.2x
P/E 2027 * -112x
Enterprise Value 3.59B 3.14B 2.9B 2.68B 5.04B 345B 5.14B 34.58B 13.57B 169B 13.48B 13.18B 581B EV / Sales 2026 *
1.32x
EV / Sales 2027 * 1.26x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day-1.17%
1 week+3.24%
Current month+0.20%
1 month+20.45%
3 months+1.33%
6 months-48.89%
Current year-38.55%
1 week 15.49
Extreme 15.49
18.63
1 month 11.84
Extreme 11.84
19.8
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
89.11
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
06-30Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
06-24Free

Director

19,599 0.0289%
06-24Free

Director

15,532 0.0229%
Change 5-day change 1-year change 3-year change Capi.($)
-1.31%+3.24%-39.19%-79.46% 1.22B
+0.20%+7.67%+18.99%-19.77% 17.68B
-0.94%-4.46%+10.65%+91.21% 1.65B
-3.09%-5.99%-34.90%+12.44% 1.06B
+3.56%-0.46%-27.98%-53.56% 616M
+0.65%-2.16%-39.60%-56.42% 554M
-3.43%-2.08%+31.51%-54.68% 455M
-2.21%-1.27%-55.23%-59.95% 385M
-2.89%-1.61%-25.00%-27.27% 341M
+2.20%+0.50%+20.68%+11.10% 301M
Average -0.83%+0.22%-14.01%-23.64% 2.43B
Weighted average by Cap. -0.25%+6.04%+9.07%-16.52%

Financials

2026 *2027 *
Net sales 2.71B 2.37B 2.19B 2.02B 3.81B 260B 3.88B 26.11B 10.24B 127B 10.18B 9.95B 439B 2.8B 2.45B 2.26B 2.09B 3.93B 269B 4.01B 26.97B 10.58B 132B 10.51B 10.28B 453B
Net income -156M -136M -126M -116M -219M -14.97B -223M -1.5B -589M -7.33B -585M -572M -25.24B -81.93M -71.6M -66.19M -61.15M -115M -7.87B -117M -789M -310M -3.85B -308M -301M -13.27B
Net Debt 2.37B 2.07B 1.91B 1.77B 3.33B 228B 3.39B 22.82B 8.95B 111B 8.9B 8.7B 384B 2.3B 2.01B 1.86B 1.72B 3.23B 221B 3.29B 22.14B 8.69B 108B 8.63B 8.44B 372B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-14 US$17.56 -1.84% 250,767
26-07-13 US$17.89 -2.08% 1,123,060
26-07-10 US$18.27 +4.76% 1,278,522
26-07-09 US$17.44 +1.10% 1,074,513
26-07-08 US$17.25 +1.47% 1,756,442
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
17.89USD
Average target price
20.50USD
Spread / Average Target
+14.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock